These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
257 related articles for article (PubMed ID: 33807733)
1. Advanced Pediatric Diffuse Pontine Glioma Murine Models Pave the Way towards Precision Medicine. Chen Z; Peng P; Zhang X; Mania-Farnell B; Xi G; Wan F Cancers (Basel); 2021 Mar; 13(5):. PubMed ID: 33807733 [TBL] [Abstract][Full Text] [Related]
2. Current Murine Models and New Developments in H3K27M Diffuse Midline Gliomas. Welby JP; Kaptzan T; Wohl A; Peterson TE; Raghunathan A; Brown DA; Gupta SK; Zhang L; Daniels DJ Front Oncol; 2019; 9():92. PubMed ID: 30873381 [TBL] [Abstract][Full Text] [Related]
3. Detection of histone H3 K27M mutation and post-translational modifications in pediatric diffuse midline glioma via tissue immunohistochemistry informs diagnosis and clinical outcomes. Huang T; Garcia R; Qi J; Lulla R; Horbinski C; Behdad A; Wadhwani N; Shilatifard A; James C; Saratsis AM Oncotarget; 2018 Dec; 9(98):37112-37124. PubMed ID: 30647848 [TBL] [Abstract][Full Text] [Related]
4. Retrospective analysis on the consistency of MRI features with histological and molecular markers in diffuse intrinsic pontine glioma (DIPG). Giagnacovo M; Antonelli M; Biassoni V; Schiavello E; Warmuth-Metz M; Buttarelli FR; Modena P; Massimino M Childs Nerv Syst; 2020 Apr; 36(4):697-704. PubMed ID: 31848724 [TBL] [Abstract][Full Text] [Related]
5. Preclinical evaluation of convection-enhanced delivery of liposomal doxorubicin to treat pediatric diffuse intrinsic pontine glioma and thalamic high-grade glioma. Sewing ACP; Lagerweij T; van Vuurden DG; Meel MH; Veringa SJE; Carcaboso AM; Gaillard PJ; Peter Vandertop W; Wesseling P; Noske D; Kaspers GJL; Hulleman E J Neurosurg Pediatr; 2017 May; 19(5):518-530. PubMed ID: 28291423 [TBL] [Abstract][Full Text] [Related]
6. The transcription factor Olig2 is important for the biology of diffuse intrinsic pontine gliomas. Anderson JL; Muraleedharan R; Oatman N; Klotter A; Sengupta S; Waclaw RR; Wu J; Drissi R; Miles L; Raabe EH; Weirauch ML; Fouladi M; Chow LM; Hoffman L; DeWire M; Dasgupta B Neuro Oncol; 2017 Aug; 19(8):1068-1078. PubMed ID: 28339768 [TBL] [Abstract][Full Text] [Related]
7. Therapeutic targeting of polycomb and BET bromodomain proteins in diffuse intrinsic pontine gliomas. Piunti A; Hashizume R; Morgan MA; Bartom ET; Horbinski CM; Marshall SA; Rendleman EJ; Ma Q; Takahashi YH; Woodfin AR; Misharin AV; Abshiru NA; Lulla RR; Saratsis AM; Kelleher NL; James CD; Shilatifard A Nat Med; 2017 Apr; 23(4):493-500. PubMed ID: 28263307 [TBL] [Abstract][Full Text] [Related]
15. Progress in diffuse intrinsic pontine glioma: advocating for stereotactic biopsy in the standard of care. Williams JR; Young CC; Vitanza NA; McGrath M; Feroze AH; Browd SR; Hauptman JS Neurosurg Focus; 2020 Jan; 48(1):E4. PubMed ID: 31896081 [TBL] [Abstract][Full Text] [Related]